Monimus Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Buy
90,396
+6,341
+8% +$84.7K 0.88% 35
2025
Q1
$857K Buy
+84,055
New +$857K 0.73% 36